[Hyperlipidemia in hemodialysis patients].
Nishikawa
O
O
Third Department of Internal Medicine, Wakayama Medical College.
Mune
M
M
Yukawa
S
S
D000924:Anticholesteremic Agents / Q000627:therapeutic use; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use; D006951:Hyperlipoproteinemias / Q000188:drug therapy / Q000209:etiology*; D015228:Hypertriglyceridemia / Q000188:drug therapy / Q000209:etiology*; D000960:Hypolipidemic Agents / Q000627:therapeutic use; D007009:Hypolipoproteinemias / Q000188:drug therapy / Q000209:etiology*; D008054:Lipid Peroxides / Q000378:metabolism; D017270:Lipoprotein(a) / Q000097:blood; D008075:Lipoproteins, HDL / Q000097:blood; D006435:Renal Dialysis / Q000009:adverse effects*; D014810:Vitamin E / Q000627:therapeutic use
D000924:Anticholesteremic Agents; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D000960:Hypolipidemic Agents; D008054:Lipid Peroxides; D017270:Lipoprotein(a); D008075:Lipoproteins, HDL; D014810:Vitamin E